Wasteland Capital
Global Markets Investor, US, UK & European Assets
Intel's stock has run well ahead of itself, and it will take a long time to generate solid earnings. A post the author replies to notes it trades near 100x forward earnings, with much of the expected earnings resting on circular deals and compute-purchase promises from two companies nowhere near profitable. x.comÂ
Intel looks priced for too much good news before it has actually delivered on anything. Its CPU story was carrying the share price. x.comÂ
Intel's solid miss fits a longstanding negative view of the stock. ZeroHedge reported fourth-quarter adjusted EPS guidance of $0.25 versus $0.45 expected and revenue guidance of $15 billion to $16 billion versus $17.29 billion expected. x.comÂ
Intel's data-center and foundry growth could outlast its PC-driven weak guidance. Data-center revenue rose 78% to $7.3bn and foundry revenue rose 58%, but PCs still account for about half the business and management expects their slowdown through at least the first half of next year. Q4 revenue and margin guidance disappointed, and $0.17 of quarterly EPS came from a mark-to-market gain. The selloff prices in the PC problem, not the turnaround. Overweight; $130 target. x.com x.comÂ
Intel's recovery looks fragile because PC softness could persist through at least the first half of 2027. Management's weak Q4 outlook suggests the pressure may outlast one disappointing forecast. x.comÂ
Intel's lack of real AI or foundry plans is showing in weak Q4 guidance. It forecasts $15 billion to $16 billion of revenue versus $17.08 billion consensus and non-GAAP EPS of $0.25 versus $0.44, despite Q3 EPS of $0.52 and revenue of $16.51 billion beating expectations. x.comÂ
Intel's poor EMIB-T packaging yields threaten its plans for next year. Per a confidential source, yields are very poor, and EMIB-T may now slip into the following year. The 14A PDK 0.9 matters more for the long term. Intel remains a very strong long-term bull case because yields should improve, though setbacks can arise along the way; whether to avoid this near-term risk is a personal judgment. x.com x.com x.com x.com x.com x.comÂ
Intel's weak guidance undermines the turnaround bet. The whole turnaround now looks like a scam, though the view will be reassessed later. x.com x.comÂ
Intel's high valuation is hard to justify while its foundry turnaround remains unproven. At about 59x forward earnings, nearly three times TSMC's 19x, Intel has slower projected revenue growth; its foundry lost $2.09 billion in Q2 2026, while TSMC's Q3 operating margin was 58.7%. A politician's stock purchase alone does not make Intel a buy. x.com x.comÂ
Intel's near-term growth is constrained by a Kiryat Gat factory blast and memory-driven PC weakness. The weak Q4 outlook calls for answers: the blast looks set to cut roughly $300 million of revenue in Q4 and could have a similar impact in Q1, limiting data-center growth. Fab ownership gives Intel pricing power and enterprise demand is strong; external foundry customers would add another tailwind if won. CEO Lip-Bu Tan said Nova Lake will allow Intel to take back share. x.com x.com x.com x.com … Show more
Intel looks expensive even against sales despite its earlier revenue recovery: at 10x sales versus roughly 5x for chipmakers, the screen puts fair value at $40.45-$51.48 against $104.70. This adds a sales-based valuation warning to the prior earnings concern; it is a levels-only comparison using reported figures, not fundamental diligence. x.comÂ
